Dr. Zeeshan Ahmed is invited to participate and speak at the Artificial Intelligence in Drug Discovery event, organized by the New Jersey Economic Development Authority – Life Sciences, which will take place Tue Sep 19, 2023 at 211 Warren Street, Newark, NJ 07103.
Dive into the fascinating world of Artificial Intelligence (AI) in the realm of drug discovery. This event brings together experts, researchers, and enthusiasts to explore the potential of AI in revolutionizing the pharmaceutical industry. Discover how AI algorithms and machine learning techniques are transforming the drug discovery process and accelerating the identification of potential drug candidates. Get inspired by real-world success stories and learn about the latest advancements in AI technologies. Whether you’re a scientist, a student, or simply curious about the intersection of AI and drug discovery, this event offers a unique opportunity to network with like-minded individuals and gain valuable insights. Don’t miss out on this chance to be at the forefront of innovation in the pharmaceutical field!
Introductions:
- Kara Moore, Sector Lead for Life Sciences at the New Jersey Economic Development Authority
- Pavita Howe, VP of Innovation and Entrepreneurship at BioNJ
Panel:
- Tyler Bryk, Senior Manager of AI & Machine Learning at PTC Therapeutics
- Nina Keshavarzi, Founder and CEO of Celine Therapeutics
- Zeeshan Ahmed, Assistant Professor at Rutgers, IFH & RWJ Med School
- Qi Tang, Director of Data Sciences, Bioimaging and Digital Pathology at Sanofi
- Hamdi Cavusoglu, Program Director for the Merck Digital Sciences Studio (moderator)